Application Deadline
May 31, 2024

Chief Medical Officer

Job description

We are looking for a Chief Medical Officer will play a pivotal role in shaping the clinical strategy and ensuring the highest standards of medical excellence. You will lead and oversee the implementation of prospective clinical validation of innovative cancer diagnostic tests, driving the development and implementation of advanced diagnostic solutions to transform breast cancer care. You will also be in charge of direct communication with breast cancer patients and their oncologists.


Direct communication with patients and oncologists:

  • Direct communication with breast cancer patients
  • Presenting the value of Multiplex8+ and the results to the oncologists

Prospective clinical validation:

  • Lead the design and execution of clinical study to validate and refine MultiplexDX diagnostic technologies.
  • Collaborate with external clinical sites and internal teams to collect, analyze, and interpret clinical data for product development and validation.

Clinical Strategy Development:

  • Define and execute the clinical strategy in alignment with the company's mission and goals.
  • Stay abreast of the latest advancements in oncology and molecular diagnostics to drive innovation.

Key Opinion Leader Engagement:

  • Foster relationships with key opinion leaders, oncologists, and researchers to build credibility and gain insights into emerging trends and clinical needs.

Medical Affairs and Education:

  • Provide medical expertise to oncologists.
  • Provide medical expertise to internal teams, including R&D, marketing, and sales, to support product development, marketing initiatives, and customer education.
  • Develop and deliver medical education programs for healthcare professionals and internal stakeholders.

Team Leadership and Development:

  • Recruit, mentor, and develop ahigh-performing medical team, providing guidance and fostering a culture of continuous learning and growth.

Cross Functional Collaboration:

  • Work closely with Management team members and cross-functional teams, including Research & Development, Operations, Regulatory Affairs, Strategy and Commercial teams, to ensure seamless development and commercialization processes.


  • Medical Doctor (MD) degree
  • Substantial clinical experience in breast cancer oncology (at least 5 years)
  • Track record of research and publications appreciated.
  • Experience in leading and managing clinical trials and studies preferred.
  • Demonstrated success in regulatory affairs and compliance in a diagnostic or pharmaceutical setting preferred.
  • Strong leadership and team-building skills with the ability to inspire and guide a diverse team of medical professionals.

Preferred skills

  • Excellent communication and presentation skills, with the ability to effectively convey complex medical information to diverse audiences in English (Czech/Slovak is an advantage).
  • In-depth knowledge of molecular diagnostics and emerging technologies in oncology.
  • Track record of successful engagement with key opinion leaders and healthcare professionals in the oncology field.
  • Business acumen and strategic thinking to drive the company's clinical initiatives.

Application process

Interested candidates are invited to submit their resume, cover letter, and any supporting materials to[]. Please include "Chief Medical Officer Application - MultiplexDX" in the subject line.


MultiplexDX is a cutting-edge cancer diagnostic company revolutionizing personalized medicine through innovative molecular diagnostics. Our mission is to improve patient outcomes by providing accurate cancer diagnoses and provide prognostic and predictive treatment signatures, enabling physicians to tailor treatments for optimal results.

For additional information, please contact

Peter Kilian
Ilkovičova 8
84104 Bratislava, Slovakia

About MultiplexDX

MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).

MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.

Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter